羟氯喹治疗类风湿关节炎的临床与结构疗效:系统综述
该系统综述检索至2017年11月的文献,纳入11项研究,评估羟氯喹单药或联合其他传统合成改善病情抗风湿药治疗类风湿关节炎的临床与结构疗效。结果显示,羟氯喹单药的临床与结构疗效与甲氨蝶呤或柳氮磺吡啶相似或更低,但联合其他改善病情抗风湿药可能提高临床疗效。
要点
- 羟氯喹单药治疗RA的临床与结构疗效不优于甲氨蝶呤或柳氮磺吡啶。
- 羟氯喹联合其他csDMARDs可能提高临床疗效。
- 对既往csDMARDs反应不足的RA患者,联合羟氯喹可提供一定临床改善。
核心结论
- 羟氯喹单药治疗RA的临床与结构疗效与甲氨蝶呤或柳氮磺吡啶相似或更低,联合其他DMARDs可能提高临床疗效。
研究设计与样本
- 系统检索MEDLINE(via PubMed)、Embase、Cochrane Library及ACR和EULAR年会摘要至2017年11月,纳入11项比较羟氯喹单药或联合其他csDMARDs治疗RA疗效的研究。
主要发现
- 文献检索发现197篇潜在相关文章和摘要,最终11项研究符合纳入标准。
- 羟氯喹单药的临床与结构疗效与甲氨蝶呤或柳氮磺吡啶相似或更低。
- 羟氯喹联合其他DMARDs可能提高临床疗效。
临床怎么用
- 对既往csDMARDs反应不足的RA患者,可考虑在联合方案中加入羟氯喹以可能改善临床疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hydroxychloroquine (HCQ) improves metabolic and cardiovascular outcomes in patients with rheumatoid arthritis (RA), but its efficacy appears to be moderate as compared to placebo. The aim of our study was to assess the current literature on the clinical and structural efficacy of HCQ in the joints of patients with RA. METHODS: We systematically searched MEDLINE (via PubMed), Embase, Cochrane Library, and the American College of Rheumatology and European League Against Rheumatism annual scientific meeting abstracts for studies available up to November 2017 comparing the efficacy of HCQ in patients with RA, in monotherapy or combined with other conventional synthetic disease-modifying antirheumatic drugs (csDMARDs). Data were extracted by 1 investigator and independently checked by a different investigator. RESULTS: The literature search revealed 197 articles and abstracts of potential interest, and 11 studies fulfilled inclusion criteria. The clinical and structural efficacy of HCQ was similar to or lower than that for methotrexate or sulfasalazine in monotherapy. HCQ combined with other DMARDs could increase the clinical efficacy. CONCLUSION: In addition to its metabolic benefit, combining HCQ with other DMARDs could provide some clinical improvement in patients with RA and inadequate response to previous csDMARDs.
引用
- Rempenault C, Combe B, Barnetche T, et al. Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review. Arthritis Care Res (Hoboken). 2020. PMID: 30629341. doi:10.1002/acr.23826
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。